It was reported that prostate cancer with a significant NE component is common in the advanced stage of the disease, especially in those patients who do not have elevated serum PSA levels [7,25,27,28], but its diagnostic role in non metastatic disease is still a matter of debate [8,29,30]. This evidence concerns the gene KLK3 and metastatic neoplasm.